Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy

A. J. Sanyal, A. M. Freedman, V. A. Luketic, P. P. Purdum, M. L. Shiffman, J. Tisnado, P. E. Cole

Research output: Contribution to journalArticle

202 Citations (Scopus)

Abstract

Background and Aims: Despite urgent sclerotherapy, active variceal hemorrhage has a 70%-90% mortality rate in patients with advanced age, sepsis, renal or pulmonary compromise, tense ascites, or deep coma. The aim of this study was to test the safety and efficacy of transjugular intrahepatic portesystemic shunt (TIPS) performed semiemergently and preceded by stabilization by balloon tamponade in such patients. Methods: Patients with actively bleeding esophageal or contiguous gastric varices despite sclerotherapy were assessed for risk of dying after emergent portacaval shunt. Those considered to be at high risk were stabilized by balloon tamponade and vasopressin/nitroglycerin and TIPS placed semiurgently within 12 hours. Balloon tamponade and pharmacological therapy were discontinued within 24 hours after TIPS in all cases. Results: Thirty-two patients met entry criteria, and 2 were excluded due to portal vein thrombosis. TIPS was successfully placed in 29 of 30 patients and achieved hemostasis in all. Thirty-day and 6-week survival rates were 63% and 60%, respectively; in those without aspiration, the 6-week survival rate was 90%. After a median follow- up period of 920 days, 46% of the original cohort was alive. Only 2 episodes of early rebleeding and 4 late rebleeds occurred. Eight patients developed encephalopathy. Stent stenosis requiring dilation occurred in 6 of 11 patients within 6 months. Conclusions: TIPS is highly effective as salvage therapy in high-risk patients with active variceal hemorrhage despite endoscopic sclerotherapy.

Original languageEnglish (US)
Pages (from-to)138-146
Number of pages9
JournalGastroenterology
Volume111
Issue number1
DOIs
StatePublished - Jan 1 1996

Fingerprint

Transjugular Intrahepatic Portasystemic Shunt
Sclerotherapy
Hemorrhage
Balloon Occlusion
Survival Rate
Surgical Portacaval Shunt
Salvage Therapy
Esophageal and Gastric Varices
Nitroglycerin
Brain Diseases
Coma
Portal Vein
Hemostasis
Vasopressins
Ascites
Stents
Dilatation
Sepsis
Pathologic Constriction
Thrombosis

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. / Sanyal, A. J.; Freedman, A. M.; Luketic, V. A.; Purdum, P. P.; Shiffman, M. L.; Tisnado, J.; Cole, P. E.

In: Gastroenterology, Vol. 111, No. 1, 01.01.1996, p. 138-146.

Research output: Contribution to journalArticle

Sanyal, A. J. ; Freedman, A. M. ; Luketic, V. A. ; Purdum, P. P. ; Shiffman, M. L. ; Tisnado, J. ; Cole, P. E. / Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. In: Gastroenterology. 1996 ; Vol. 111, No. 1. pp. 138-146.
@article{cf4b5c88162b42cba2f02e3d88426f55,
title = "Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy",
abstract = "Background and Aims: Despite urgent sclerotherapy, active variceal hemorrhage has a 70{\%}-90{\%} mortality rate in patients with advanced age, sepsis, renal or pulmonary compromise, tense ascites, or deep coma. The aim of this study was to test the safety and efficacy of transjugular intrahepatic portesystemic shunt (TIPS) performed semiemergently and preceded by stabilization by balloon tamponade in such patients. Methods: Patients with actively bleeding esophageal or contiguous gastric varices despite sclerotherapy were assessed for risk of dying after emergent portacaval shunt. Those considered to be at high risk were stabilized by balloon tamponade and vasopressin/nitroglycerin and TIPS placed semiurgently within 12 hours. Balloon tamponade and pharmacological therapy were discontinued within 24 hours after TIPS in all cases. Results: Thirty-two patients met entry criteria, and 2 were excluded due to portal vein thrombosis. TIPS was successfully placed in 29 of 30 patients and achieved hemostasis in all. Thirty-day and 6-week survival rates were 63{\%} and 60{\%}, respectively; in those without aspiration, the 6-week survival rate was 90{\%}. After a median follow- up period of 920 days, 46{\%} of the original cohort was alive. Only 2 episodes of early rebleeding and 4 late rebleeds occurred. Eight patients developed encephalopathy. Stent stenosis requiring dilation occurred in 6 of 11 patients within 6 months. Conclusions: TIPS is highly effective as salvage therapy in high-risk patients with active variceal hemorrhage despite endoscopic sclerotherapy.",
author = "Sanyal, {A. J.} and Freedman, {A. M.} and Luketic, {V. A.} and Purdum, {P. P.} and Shiffman, {M. L.} and J. Tisnado and Cole, {P. E.}",
year = "1996",
month = "1",
day = "1",
doi = "10.1053/gast.1996.v111.pm8698192",
language = "English (US)",
volume = "111",
pages = "138--146",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy

AU - Sanyal, A. J.

AU - Freedman, A. M.

AU - Luketic, V. A.

AU - Purdum, P. P.

AU - Shiffman, M. L.

AU - Tisnado, J.

AU - Cole, P. E.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Background and Aims: Despite urgent sclerotherapy, active variceal hemorrhage has a 70%-90% mortality rate in patients with advanced age, sepsis, renal or pulmonary compromise, tense ascites, or deep coma. The aim of this study was to test the safety and efficacy of transjugular intrahepatic portesystemic shunt (TIPS) performed semiemergently and preceded by stabilization by balloon tamponade in such patients. Methods: Patients with actively bleeding esophageal or contiguous gastric varices despite sclerotherapy were assessed for risk of dying after emergent portacaval shunt. Those considered to be at high risk were stabilized by balloon tamponade and vasopressin/nitroglycerin and TIPS placed semiurgently within 12 hours. Balloon tamponade and pharmacological therapy were discontinued within 24 hours after TIPS in all cases. Results: Thirty-two patients met entry criteria, and 2 were excluded due to portal vein thrombosis. TIPS was successfully placed in 29 of 30 patients and achieved hemostasis in all. Thirty-day and 6-week survival rates were 63% and 60%, respectively; in those without aspiration, the 6-week survival rate was 90%. After a median follow- up period of 920 days, 46% of the original cohort was alive. Only 2 episodes of early rebleeding and 4 late rebleeds occurred. Eight patients developed encephalopathy. Stent stenosis requiring dilation occurred in 6 of 11 patients within 6 months. Conclusions: TIPS is highly effective as salvage therapy in high-risk patients with active variceal hemorrhage despite endoscopic sclerotherapy.

AB - Background and Aims: Despite urgent sclerotherapy, active variceal hemorrhage has a 70%-90% mortality rate in patients with advanced age, sepsis, renal or pulmonary compromise, tense ascites, or deep coma. The aim of this study was to test the safety and efficacy of transjugular intrahepatic portesystemic shunt (TIPS) performed semiemergently and preceded by stabilization by balloon tamponade in such patients. Methods: Patients with actively bleeding esophageal or contiguous gastric varices despite sclerotherapy were assessed for risk of dying after emergent portacaval shunt. Those considered to be at high risk were stabilized by balloon tamponade and vasopressin/nitroglycerin and TIPS placed semiurgently within 12 hours. Balloon tamponade and pharmacological therapy were discontinued within 24 hours after TIPS in all cases. Results: Thirty-two patients met entry criteria, and 2 were excluded due to portal vein thrombosis. TIPS was successfully placed in 29 of 30 patients and achieved hemostasis in all. Thirty-day and 6-week survival rates were 63% and 60%, respectively; in those without aspiration, the 6-week survival rate was 90%. After a median follow- up period of 920 days, 46% of the original cohort was alive. Only 2 episodes of early rebleeding and 4 late rebleeds occurred. Eight patients developed encephalopathy. Stent stenosis requiring dilation occurred in 6 of 11 patients within 6 months. Conclusions: TIPS is highly effective as salvage therapy in high-risk patients with active variceal hemorrhage despite endoscopic sclerotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0029882393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029882393&partnerID=8YFLogxK

U2 - 10.1053/gast.1996.v111.pm8698192

DO - 10.1053/gast.1996.v111.pm8698192

M3 - Article

C2 - 8698192

AN - SCOPUS:0029882393

VL - 111

SP - 138

EP - 146

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 1

ER -